Literature DB >> 22332223

Residual intraretinal retinoblastoma after chemoreduction failure.

Christopher K Hwang1, Thomas M Aaberg, Patricia Chevez-Barrios, Elizabeth Verner-Cole, Dan S Gombos, Evelyn Paysse, Murali Chintagumpala, Weiqing Gao, Hans E Grossniklaus.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22332223      PMCID: PMC3417053          DOI: 10.1001/archopthalmol.2011.1588

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


× No keyword cloud information.
  6 in total

Review 1.  Intraocular retinoblastoma presenting as ocular and orbital inflammation.

Authors:  B S Foster; S Mukai
Journal:  Int Ophthalmol Clin       Date:  1996

2.  Cancer stem cell characteristics in retinoblastoma.

Authors:  Gail M Seigel; Lorrie M Campbell; Malathi Narayan; Federico Gonzalez-Fernandez
Journal:  Mol Vis       Date:  2005-09-12       Impact factor: 2.367

3.  Blood vessel maturation in retinoblastoma tumors: spatial distribution of neovessels and mature vessels and its impact on ocular treatment.

Authors:  Yolanda Piña; Hinda Boutrid; Amy Schefler; Sander Dubovy; William Feuer; Maria-Elena Jockovich; Timothy G Murray
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-10-24       Impact factor: 4.799

4.  Angiogenesis capacity as a diagnostic marker for human eye tumors.

Authors:  D Tapper; R Langer; A R Bellows; J Folkman
Journal:  Surgery       Date:  1979-07       Impact factor: 3.982

5.  Salvage external beam radiotherapy after failed primary chemotherapy for bilateral retinoblastoma: rate of eye and vision preservation.

Authors:  M P Y Chan; J L Hungerford; J E Kingston; P N Plowman
Journal:  Br J Ophthalmol       Date:  2009-03-26       Impact factor: 4.638

6.  Clinical spectrum of diffuse infiltrating retinoblastoma in 34 consecutive eyes.

Authors:  Carol L Shields; Fariba Ghassemi; Samuray Tuncer; Archana Thangappan; Jerry A Shields
Journal:  Ophthalmology       Date:  2008-10-29       Impact factor: 12.079

  6 in total
  1 in total

1.  Retinoblastoma. Fifty years of progress. The LXXI Edward Jackson Memorial Lecture.

Authors:  Hans E Grossniklaus
Journal:  Am J Ophthalmol       Date:  2014-07-24       Impact factor: 5.258

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.